In conclusion, a set of candidate predictive biomarkers for5-fluorouracil, oxaliplatin, and BEZ235 are described that warrant further study.Amplification of the putative oncogene TRIB1 has been described forthe first time in a cohort of CRC patients. The gene discussed is TRIB1; the disease is colorectal carcinoma.